<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medical  Diagnosis</journal-title></journal-title-group><issn pub-type="epub">2164-540X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/MD.2019.92011</article-id><article-id pub-id-type="publisher-id">MD-30693</article-id><article-categories><subj-group subj-group-type="heading"><subject>MD20190200000_80178139.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  自身免疫性疾病相关的指标
  Indicators Related to Autoimmune Diseases
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>武</surname><given-names>凯丽</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>内蒙古医科大学，内蒙古 呼和浩特</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>06</month><year>2019</year></pub-date><volume>09</volume><issue>02</issue><fpage>57</fpage><lpage>60</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  自身免疫性疾病由于抗原抗体复合物广泛沉积于血管壁等原因导致全身多器官损害，称系统性自身免疫病。习惯上又称之为胶原病或结缔组织病，这是由于免疫损伤导致血管壁及间质的纤维素样坏死性炎症及随后产生多器官的胶原纤维增生所致。CRP的单体在病变早期具有促炎效果，巨噬细胞移动抑制因子(MIF)在炎症过程中使炎症反应加剧，自身免疫性疾病中1磷酸鞘氨醇(S1P)的水平增加；因此我们可以推测单体CRP、MIF是否与S1P具有相关关系。
   Autoimmune diseases are called systemic autoimmune diseases because of the extensive deposi-tion of antigen-antibody complexes in the vascular wall and other reasons leading to systemic multiple organ damage. It is also known as collagen disease or connective tissue disease, which is caused by cellulose-like necrotizing inflammation of vascular wall and interstitium and subsequent proliferation of collagen fibers in multiple organs caused by immune injury. CRP monomer CRP has pro-inflammatory effect in the early stage of lesion, macrophage migration inhibitory factor (MIF) aggravates inflammation in the process of inflammation, and sphingosine 1 phosphate (S1P) level increases in autoimmune diseases; therefore, we can speculate whether CRP and MIF monomer are related to S1P.
 
</p></abstract><kwd-group><kwd>单体CRP，MIF，S1P, Monomer CRP</kwd><kwd> MIF</kwd><kwd> S1P</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>自身免疫性疾病相关的指标 <sup> </sup></title><p>武凯丽</p><p>内蒙古医科大学，内蒙古 呼和浩特</p><p><img src="//html.hanspub.org/file/5-2170216x1_hanspub.png" /></p><p>收稿日期：2019年5月19日；录用日期：2019年6月3日；发布日期：2019年6月10日</p><disp-formula id="hanspub.30693-formula26"><graphic xlink:href="//html.hanspub.org/file/5-2170216x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>自身免疫性疾病由于抗原抗体复合物广泛沉积于血管壁等原因导致全身多器官损害，称系统性自身免疫病。习惯上又称之为胶原病或结缔组织病，这是由于免疫损伤导致血管壁及间质的纤维素样坏死性炎症及随后产生多器官的胶原纤维增生所致。CRP的单体在病变早期具有促炎效果，巨噬细胞移动抑制因子(MIF)在炎症过程中使炎症反应加剧，自身免疫性疾病中1磷酸鞘氨醇(S1P)的水平增加；因此我们可以推测单体CRP、MIF是否与S1P具有相关关系。</p><p>关键词 :单体CRP，MIF，S1P</p><disp-formula id="hanspub.30693-formula27"><graphic xlink:href="//html.hanspub.org/file/5-2170216x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/5-2170216x7_hanspub.png" /> <img src="//html.hanspub.org/file/5-2170216x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 单体CRP</title><p>1930年由Tillet和Francis发现一种能在Ca<sup>2+</sup>存在时与肺炎链球菌的荚膜C多糖结合的蛋白质，在19421年，Avery等先后证明C反应蛋白(CRP)是一种急性感染时出现的蛋白质，它是有对称的盘状五聚体构成，CRP是天然免疫系统的重要组分及炎症标志物，是预测炎症的因子，命名源于其能与肺炎双球菌胞壁酸C多糖中PCh残基特异识别与结合。CRP主要由肝脏合成，肾脏、血管内皮细胞、肺泡巨噬细胞、外周血淋巴细胞等亦能少量合成，属于I型急性时向反应蛋白。在人的血清、脑脊液、胸腹水等多种液体中均可检出。CRP由五个相同的亚基组成，但在进入局部病变时解离成单体构象，C反应蛋白的生物活性是基于其五聚体对称性的丧失，从而形成单体C反应蛋白，即mCRP [<xref ref-type="bibr" rid="hanspub.30693-ref1">1</xref>] ，mCRP与巨噬细胞具有强烈结合并诱导炎症的高表达，现已研究脂筏相互作用的胆固醇结合序列(CBS; aa 35~47)，具有降低并减弱mCRP的作用；由于RANKL和mCRP均有促进炎症发生的作用，然而mCRP与RANK一起发挥作用时mCRP能够抑制RANK的作用 [<xref ref-type="bibr" rid="hanspub.30693-ref2">2</xref>] ；可以认为CRP功能的发挥必须依赖于五聚体结构的解聚，形成的mCRP通过巯基这个“功能开关”发挥更高效的促炎效应 [<xref ref-type="bibr" rid="hanspub.30693-ref3">3</xref>] 。mCRP沉积在人主动脉和颈动脉粥样硬化斑块中，但不存在于健康血管中，mCRP能够诱导单核细胞趋化性增强以及单核细胞活化，使整合素MAC-1的构象变化促使活性氧的产生最后使静态和生理流动条件下的单核细胞发生粘附，进一步促进炎症的发生 [<xref ref-type="bibr" rid="hanspub.30693-ref4">4</xref>] 。mCRP可能是CRP配体结合功能的固定、配体结合副产物，CRP与修饰型低密度脂蛋白(LDL)结合，然而与氧化低密度脂蛋白的结合需要酸性的酸碱度条件，生理酸碱度的结合存在争议，因此在病理状况下，一旦身体酸碱度发生改变，促炎过程将被启动 [<xref ref-type="bibr" rid="hanspub.30693-ref5">5</xref>] 。目前关于mCRP的研究方面不断增加，所累积到各个系统，尤其是在免疫系统中，但是最终原理都是通过促进CRP蛋白解离成为mCRP，促进炎症的发生，进而促进疾病的爆发，因此我们能否通过抑制炎症的爆发，来阻止疾病的进一步发展，值得我们进一步研究。</p></sec><sec id="s4"><title>2. MIF</title><p>自身免疫性疾病是指机体对自身抗原发生免疫反应而导致自身组织损害所引起的疾病，主要是通过细胞免疫以及体液免疫的增加的一种疾病。MIF作为一种作用广泛的前炎症因子，MIF具有活化巨噬细胞、抑制其游走移动，增强其黏附、吞噬及杀灭肿瘤活性的作用，并可刺激炎症细胞分泌TNF-α、IL-1和NO及对抗激素抑制单核细胞分泌IL-1，IL-6，IL-8的作用，结论肿瘤坏死因子-α (TNF-α)、白细胞介素6 (IL-6)、白细胞介素17 (IL-17)在类风湿关节炎早发动脉粥样硬化患者中均高表达，可能共同参与了此类患者中动脉粥样硬化的发病 [<xref ref-type="bibr" rid="hanspub.30693-ref6">6</xref>] 。在活动期SLE患者血液中的炎症因子水平明显高于非活动期SLE患者 [<xref ref-type="bibr" rid="hanspub.30693-ref7">7</xref>] 。与MIF相关的自身免疫病包括类风湿性关节炎(RA)、系统性红斑狼疮(SLE)、增生性肾小球肾炎等 [<xref ref-type="bibr" rid="hanspub.30693-ref8">8</xref>] 。MIF在自身免疫性肾病中的作用十分巨大。MIF广泛表达于多种系统、组织的细胞中，国外学者通过体外和体内实验相继发现肾小球系膜细胞、内皮细胞、上皮细胞及肾小管上皮细胞等肾脏固有细胞也可产生MIF，其变化与肾脏损害程度相关 [<xref ref-type="bibr" rid="hanspub.30693-ref9">9</xref>] ，并且应用抗MIF中和抗体干预可明显减轻肾组织内巨噬细胞浸润及肾脏病理损害，改善肾功能，说明MIF参与肾脏疾病。MIF在炎症过程中与各种细胞和炎症因子、致炎物质产生相互作用，使炎症反应加剧 [<xref ref-type="bibr" rid="hanspub.30693-ref10">10</xref>] 。我们仅以风湿和狼疮作以简单的概述，MIF在RA滑膜组织中表达，并通过提高血管内皮细胞的VEGF (内皮细胞生长因子)而促进RA滑膜血管生成而发挥重要的生理作用。在对RA的研究发现，MIF通过下调p53水平以拮抗滑膜细胞的凋亡，MIF或许是治疗RA进展的药物靶点，有望通过抑制 RA患者中MIF的表达从而延缓疾病的进展，改善患者的生活质量 [<xref ref-type="bibr" rid="hanspub.30693-ref11">11</xref>] 。MIF主要由激活的T细胞和巨噬细胞产生，而系统性红斑狼疮是由于以免疫性炎症为突出变现的弥漫性结缔组织病，是自身免疫性疾病的经典原型，其免疫紊乱以T细胞活化、B细胞多克隆激活产生大量自身抗体为特征的一种免疫性疾病，MIF具有多种前炎症因子的功能，反过来又可促进T细胞增殖活化及B细胞多克隆激活，产生大量自身抗体和多种细胞因子等 [<xref ref-type="bibr" rid="hanspub.30693-ref12">12</xref>] ，因此我们可以MIF在自身免疫性疾病中发挥着启动炎症以及促进炎症发生发展的过程。</p></sec><sec id="s5"><title>3. S1P对自身免疫性疾病的影响</title><p>S1P之所以能够发挥出较强的细胞增殖抑制作用，主要作用于Ｔ细胞以及活化的CD4 + T细胞 [<xref ref-type="bibr" rid="hanspub.30693-ref13">13</xref>] ，信号通过B2肾上腺素能受体参与淋巴细胞的控制从而改变趋化剂受体的反应性 [<xref ref-type="bibr" rid="hanspub.30693-ref14">14</xref>] 。嗜中性粒细胞中C5a与S1P之间的相互作用，能够促进噬中性粒细胞抗体的活化，在c5a引发的嗜中性粒细胞中检测到S1P的生成对免疫细胞具有其他作用例如调控嗜中性粒细胞的活化，这种机制可能与自身行免疫性疾病密切相关 [<xref ref-type="bibr" rid="hanspub.30693-ref15">15</xref>] 。SIP参与淋巴细胞的迁移以及细胞因子及趋化因子的生成 [<xref ref-type="bibr" rid="hanspub.30693-ref16">16</xref>] 。S1P和S1PR信号在炎症组织中的免疫细胞和淋巴细胞滞留的重要性，S1P是一种生物活性脂质中介体，S1P对淋巴细胞的影响分化与免疫反应有关 [<xref ref-type="bibr" rid="hanspub.30693-ref17">17</xref>] 。Christoffersen等发现载脂蛋白M是小亲脂性信号的主要载体 [<xref ref-type="bibr" rid="hanspub.30693-ref18">18</xref>] 。载脂蛋白M是典型的脂质运载蛋白含有疏水性结合袋，主要携带S1P，小信号分子S1P与多种疾病的生理和病理相关 [<xref ref-type="bibr" rid="hanspub.30693-ref19">19</xref>] 。S1P可与细胞特定受体结合，在细胞生长、增值、血管生成，抑制凋亡及淋巴细胞迁移等方面发挥作用 [<xref ref-type="bibr" rid="hanspub.30693-ref20">20</xref>] 。炎症因子能够促进血管的通透性可激活SphKs，进而催化磷酸化鞘氨醇产生S1P [<xref ref-type="bibr" rid="hanspub.30693-ref21">21</xref>] 。</p></sec><sec id="s6"><title>4. 展望</title><p>mCRP与MIF均具有促进炎症加剧的功能，自身免疫性疾病又是血管壁及间质的纤维素样坏死性炎症，在自身免疫性疾病中S1P的水平明显增高，也是促进自身免疫性疾病中的关键物质，可以想象如果抑制mCRP与MIF促炎过程或者减少S1P的水平进而延缓自身免疫性疾病的进展，这在目前的研究中少之又少，为以后相关的免疫性疾病提供疾病治疗作用的靶点。</p></sec><sec id="s7"><title>文章引用</title><p>武凯丽. 自身免疫性疾病相关的指标Indicators Related to Autoimmune Diseases[J]. 医学诊断, 2019, 09(02): 57-60. https://doi.org/10.12677/MD.2019.92011</p></sec><sec id="s8"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.30693-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Molins, B., Pena, E., Del, T.R., et al. (2011) Monomeric C-Reactive Protein Is Prothrombotic and Dissociates from Circulating Pen-tameric C-Reactive Protein on Adhered Activated Platelets under Flow. Cardiovascular Research, 92, 328-337.&lt;br&gt; https://doi.org/10.1093/cvr/cvr226</mixed-citation></ref><ref id="hanspub.30693-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">贾哲坤. 单体C反应蛋白调节破骨细胞分化的机制研究[D]: [博士学位论文]. 兰州: 兰州大学, 2018.</mixed-citation></ref><ref id="hanspub.30693-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">白彩娟. C-反应蛋白的变构及其单体的功能[D]: [博士学位论文]. 兰州: 兰州大学, 2013.</mixed-citation></ref><ref id="hanspub.30693-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Eisenhardt, S.U., Habersberger, J., Murphy, A., et al. (2009) Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques. Circulation Research, 105, 128-137. &lt;br&gt;https://doi.org/10.1161/CIRCRESAHA.108.190611</mixed-citation></ref><ref id="hanspub.30693-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Singh, S.K., Hammond, D.J. and Agrawal, A. (2010) Atherosclero-sis-Related Functions of C-Reactive Protein. Cardiovascular &amp; Haematological Disorders—Drug Targets (Formerly Current D), 10, 235-240. &lt;br&gt;https://doi.org/10.2174/187152910793743841</mixed-citation></ref><ref id="hanspub.30693-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">陈英, 张文玲, 黄涛, 等. 炎症因子TNF-α、IL-6、IL-17与类风湿关节炎并发动脉粥样硬化的关系[J]. 免疫学杂志, 2017, 33(3): 90-94.</mixed-citation></ref><ref id="hanspub.30693-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">顾蔚, 张鲁勤, 胡海波, 等. 炎症因子对系统性红斑狼疮免疫易栓状态的影响[J]. 中国综合临床, 2016, 32(11): 988-992.</mixed-citation></ref><ref id="hanspub.30693-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Onodera, S., Tanji, H., Suzuki, K., et al. (1999) High Expression of Macrophage Migration Inhibitory Factor in the Synovial Tissue of Rheumatoid Joints. Cytokine, 11, 163-167. &lt;br&gt; https://doi.org/10.1006/cyto.1998.0402</mixed-citation></ref><ref id="hanspub.30693-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Tesh, G.H., Nikolic-Paterson, D.J., Atkins, R.C., et al. (1998) Rat Mesangial Cells Express Macrophage Migration Inhibitory Factor in Vitro and in Vivo. American Society of Nephrology, 9, 417-424.</mixed-citation></ref><ref id="hanspub.30693-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Calandra, T., Bemhagen, J., Metz, C.N., et al. (1995) MIF as a Glucocorticoid-Induced Modulation of Cytokine Production. Nature, 377, 68-71. &lt;br&gt;https://doi.org/10.1038/377068a0</mixed-citation></ref><ref id="hanspub.30693-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">严瀚, 刘恩志, 周汉城, 钟波夫, 芦虎. 类风湿关节炎中巨噬细胞移动抑制因子对内皮细胞功能及血管内皮生长因子的影响[J]. 中华关节外科杂志(电子版), 2013, 7(3): 373-377.</mixed-citation></ref><ref id="hanspub.30693-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, T., Abe, R., Ohkawara, A., et al. (1999) Increased Production of Macrophage Migration Inhibitory Factor by PBNCs of Atopic Dermatitis. Journal of Allergy and Clinical Immunology, 104, 659-664. &lt;br&gt;https://doi.org/10.1016/S0091-6749(99)70339-8</mixed-citation></ref><ref id="hanspub.30693-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">高莹, 田美丽, 宋丽萍. SPHK-1在非小细胞肺癌H460细胞耐药株中的作用[J]. 西安交通大学学报(医学版), 2017, 38(2): 172-175.</mixed-citation></ref><ref id="hanspub.30693-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Nakai, A., Hayano, Y., Furuta, F., et al. (2014) Control of Lymphocyte Egress from Lymph Nodes through β 2-Adrenergic Receptors. Journal of Experimental Medicine, 211, 2583. &lt;br&gt; https://doi.org/10.1084/jem.20141132</mixed-citation></ref><ref id="hanspub.30693-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Hao, J., Huang, Y.M., Zhao, M.H., et al. (2014) The Interaction between C5a and Sphingosine-1-Phosphate in Neutrophils for Antineutrophil Cytoplasmic Antibody Mediated Activation. Arthritis Research &amp; Therapy, 16, R142. &lt;br&gt;https://doi.org/10.1186/ar4604</mixed-citation></ref><ref id="hanspub.30693-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Garris, C.S., Blaho, V.A., Hla, T., et al. (2014) Sphingosine-1-Phosphate Receptor 1 Signalling in T Cells: Trafficking and Beyond. Immunology, 142, 347-353. &lt;br&gt;https://doi.org/10.1111/imm.12272</mixed-citation></ref><ref id="hanspub.30693-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Masayo, A., Hiroaki, A., Rajesh, R., et al. (2016) Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. Mediators of Inflammation, 2016, Article ID: 8606878. &lt;br&gt;https://doi.org/10.1155/2016/8606878</mixed-citation></ref><ref id="hanspub.30693-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Christoffersen, C. and Dahlbäck, B. (2011) Endothelium-Protective Sphingo-sine-1-Phosphate Provided by HDL-Associated Apolipoprotein M. Proceedings of the National Academy of Sciences of the United States, 108, 9613-9618. &lt;br&gt;https://doi.org/10.1073/pnas.1103187108</mixed-citation></ref><ref id="hanspub.30693-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hajny, S. and Christoffersen, C. (2017) A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. International Journal of Molecular Sciences, 18, 1636. &lt;br&gt;https://doi.org/10.3390/ijms18081636</mixed-citation></ref><ref id="hanspub.30693-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Proia, R.L. and Hla, T. (2015) Emerging Biology of Sphingosine-1-Phosphate: Its Role in Pathogenesis and Therapy. Journal of Clinical Investigation, 125, 1379. &lt;br&gt; https://doi.org/10.1172/JCI76369</mixed-citation></ref><ref id="hanspub.30693-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">张峥嵘, 吴虹, 戴丽, 等. 1-磷酸鞘氨醇及受体对自身免疫性疾病血管新生的影响[J]. 中国药理学通报, 2017, 33(9): 1190-1194.</mixed-citation></ref></ref-list></back></article>